Bird Flu (H5N1 Avian Influenza) Vaccine Clinical Trials 
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.Phase I Clinical Trial to Evaluate the Safety and Immunogenicity of Inactivated Influenza A/H5N1 Vaccine Administered Intradermally With or Without Topical Aldara in Healthy Young Adults
Conditions: Avian Influenza; Influenza Immunisation Interventions: Other: Aqueous Cream B.P.; Drug: Imiquimod; Biological: Influenza Virus Vaccine, Monovalent A/H5N1 A/Vietnam/1203/04 Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 21, 2018 Category: Research Source Type: clinical trials
A Study to Evaluate Safety, Immunogenicity, and Lot-to-Lot Consistency of H5N1 Subunit Influenza Virus Vaccine in Healthy Adult Subjects ≥18 Years of Age
Condition: Avian InfluenzaInterventions: Biological: aH5N1c; Biological: PlaceboSponsors: Seqirus; Biomedical Advanced Research and Development AuthorityRecruiting - verified July 2016 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 18, 2016 Category: Research Source Type: clinical trials
A Study to Evaluate Safety, Immunogenicity, and Lot-to-Lot Consistency of H5N1 Subunit Influenza Virus Vaccine in Healthy Adult Subjects ≥18 Years of Age
< b > Condition < /b > : Avian Influenza < br/ > < b > Interventions < /b > : Biological: aH5N1c; Biological: Placebo < br/ > < b > Sponsors < /b > : Seqirus; Biomedical Advanced Research and Development Authority < br/ > < b > Recruiting < /b > - verified July 2016 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 18, 2016 Category: Research Source Type: clinical trials
A Study to Evaluate Safety, Immunogenicity, and Lot-to-Lot Consistency of H5N1 Subunit Influenza Virus Vaccine in Healthy Adult Subjects ≥18 Years of Age
Condition: Avian Influenza Interventions: Biological: aH5N1c; Biological: Placebo Sponsors: Seqirus; Biomedical Advanced Research and Development Authority Recruiting - verified July 2016 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 18, 2016 Category: Research Source Type: clinical trials
A Study to Evaluate Safety, Immunogenicity, and Lot-to-Lot Consistency of H5N1 Subunit Influenza Virus Vaccine in Healthy Adult Subjects ≥18 Years of Age
< b > Condition < /b > : Avian Influenza < br/ > < b > Interventions < /b > : Biological: aH5N1c; Biological: Placebo < br/ > < b > Sponsors < /b > : Seqirus; Biomedical Advanced Research and Development Authority < br/ > < b > Recruiting < /b > - verified July 2016 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 18, 2016 Category: Research Source Type: clinical trials
A Study to Evaluate Safety, Immunogenicity, and Lot-to-Lot Consistency of H5N1 Subunit Influenza Virus Vaccine in Healthy Adult Subjects ≥18 Years of Age
Condition: Avian InfluenzaInterventions: Biological: aH5N1c; Biological: PlaceboSponsors: Seqirus; Biomedical Advanced Research and Development AuthorityRecruiting - verified July 2016 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 18, 2016 Category: Research Source Type: clinical trials
A Study to Evaluate Safety, Immunogenicity, and Lot-to-Lot Consistency of H5N1 Subunit Influenza Virus Vaccine in Healthy Adult Subjects ≥18 Years of Age
< b > Condition < /b > : Avian Influenza < br/ > < b > Interventions < /b > : Biological: aH5N1c; Biological: Placebo < br/ > < b > Sponsors < /b > : Seqirus; Biomedical Advanced Research and Development Authority < br/ > < b > Recruiting < /b > - verified July 2016 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 18, 2016 Category: Research Source Type: clinical trials
